Decentralization of Next-Generation RNA Sequencing-Based MammaPrint® and BluePrint® Kit at University Hospitals Leuven and Curie Institute Paris

A previously developed and centrally validated MammaPrint® (MP) and BluePrint® (BP) targeted RNA next-generation sequencing (NGS) kit was implemented and validated in two large academic European hospitals. Additionally, breast cancer molecular subtypes by MP and BP RNA sequencing were compared with...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Transl Oncol
Päätekijät: Slembrouck, Laurence, Darrigues, Lauren, Laurent, Cecile, Mittempergher, Lorenza, Delahaye, Leonie JMJ, Vanden Bempt, Isabelle, Vander Borght, Sara, Vliegen, Liesbet, Sintubin, Petra, Raynal, Virginie, Bohec, Mylene, Reyes, Cécile, Rapinat, Audrey, Helsmoortel, Céline, Jongen, Lynn, Hoste, Griet, Neven, Patrick, Wildiers, Hans, Smeets, Ann, Nevelsteen, Ines, Punie, Kevin, Van Nieuwenhuysen, Els, Han, Sileny, Vincent Salomon, Anne, Laas Faron, Enora, Cynober, Timothé, Gentien, David, Baulande, Sylvain, Snel, Mireille HJ, Witteveen, Anke T, Neijenhuis, Sari, Glas, Annuska M, Reyal, Fabien, Floris, Giuseppe
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Neoplasia Press 2019
Aiheet:
Original article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6742807/
https://ncbi.nlm.nih.gov/pubmed/31513983
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2019.08.008
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia